GH Research PLC

XNAS

Last traded price · USD

$19.93

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $19.93
Volume: —
Day's high: —
Day's low: —

In brief

GH Research PLC is a US-listed company listed on Nasdaq, valued at about $1.37B.
Its shares closed at $19.93 on 4 Nov 2026, up 47.6% over the past year.
From India you can buy GHRS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy GH Research PLC (GHRS) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole GHRS share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade GHRS options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY over 1 year
1 month: −7.4% (SPY −1.6%). 3 months: −31.6% (SPY −0.4%). 1 year: +47.6% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: GHRS, SPY · as of 4 Nov 2026
7.0 days to cover short interest
2.0M shares were sold short at the 15 Oct 2026 settlement, 2.9% of the 68.6M shares outstanding; covering them would take 7.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $19.93 was 15.4% below its 50-day average ($23.56) and 7.7% below its 200-day average ($21.60). It has closed below the 200-day for 21 sessions, since 7 Oct 2026. The 50-day average crossed above the 200-day on 25 Feb 2025, 426 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
41% of the way up its 52-week range
Closed at $19.93 on 4 Nov 2026: 36.6% below the 52-week high of $31.44 (7 Aug 2026) and 65.5% above the low of $12.04 (16 Dec 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−7.4%

6 months−11.2%

1 year+47.6%

5 years−21.1%

Newswire

About

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Website

Notable moves

January 7, 2026
+27.12%
February 3, 2025
+69.72%
August 5, 2022
+29.83%

GH Research PLC

XNAS

Last traded price · USD

$19.93

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $19.93
Volume: —
Day's high: —
Day's low: —

In brief

GH Research PLC is a US-listed company listed on Nasdaq, valued at about $1.37B.
Its shares closed at $19.93 on 4 Nov 2026, up 47.6% over the past year.
From India you can buy GHRS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy GH Research PLC (GHRS) shares from India?

Do I need the price of a whole GHRS share to invest?

How much can I invest in US stocks in a year?

Can I trade GHRS options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY over 1 year
1 month: −7.4% (SPY −1.6%). 3 months: −31.6% (SPY −0.4%). 1 year: +47.6% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: GHRS, SPY · as of 4 Nov 2026
7.0 days to cover short interest
2.0M shares were sold short at the 15 Oct 2026 settlement, 2.9% of the 68.6M shares outstanding; covering them would take 7.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $19.93 was 15.4% below its 50-day average ($23.56) and 7.7% below its 200-day average ($21.60). It has closed below the 200-day for 21 sessions, since 7 Oct 2026. The 50-day average crossed above the 200-day on 25 Feb 2025, 426 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
41% of the way up its 52-week range
Closed at $19.93 on 4 Nov 2026: 36.6% below the 52-week high of $31.44 (7 Aug 2026) and 65.5% above the low of $12.04 (16 Dec 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−7.4%

6 months−11.2%

1 year+47.6%

5 years−21.1%

Newswire

About

Website

Notable moves

January 7, 2026
+27.12%
February 3, 2025
+69.72%
August 5, 2022
+29.83%

GH Research PLC

GH Research PLC in brief

Ahead of SPY over 1 year

7.0 days to cover short interest

Below its 50- and 200-day averages

41% of the way up its 52-week range

GH Research PLC

GH Research PLC in brief

Ahead of SPY over 1 year

7.0 days to cover short interest

Below its 50- and 200-day averages

41% of the way up its 52-week range